Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Scholten

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Hepatology (Baltimore, Md.)|March 5, 2011
Questioning the challenging role of epithelial-to-mesenchymal transition in liver injuryDavid Scholten, Ralf Weiskirchen
Nature Clinical Practice. Gastroenterology & Hepatology|July 17, 2008
What is the potential role of antifibrotic agents for the treatment of liver disease?Bernd Schnabl, David Scholten, David A Brenner
World Journal of Biological Chemistry|June 13, 2014
Endoglin in liver fibrogenesis: Bridging basic science and clinical practiceSteffen K Meurer, Muhammad Alsamman, David Scholten, et al.
Hepatobiliary Surgery and Nutrition|February 26, 2015
Contribution of bone marrow-derived fibrocytes to liver fibrosisJun Xu, Min Cong, Tae Jun Park, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 31, 2021
Multiplexed Tissue TomographyEvan H Phillips, David Scholten, Amy C Flor, et al.
Cancers|February 13, 2025
Timing Anti-PD-L1 Checkpoint Blockade Immunotherapy to Enhance Tumor IrradiationSteve Seung-Young Lee, Joanna Pagacz, Sera Averbek, et al.
Gastroenterology|June 16, 2010
Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in miceDavid Scholten, Christoph H Osterreicher, Anjali Scholten, et al.
International Review of Cell and Molecular Biology|April 26, 2025
Circulation tumor cell isolation and enrichment technologiesYoubin Zhang, David Scholten, Wenan Qiang, et al.
Plos One|June 27, 2013
The chemokine CCL3 promotes experimental liver fibrosis in miceDaniel Heinrichs, Marie-Luise Berres, Andreas Nellen, et al.
Journal of Internal Medicine|November 22, 2022
Intravenous immunoglobulins in the treatment of post-COVID: A case-control studyMaximilian Hogeweg, Adrian Doevelaar, Sonja Rieckmann, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Hepatology (Baltimore, Md.)|March 5, 2011
Questioning the challenging role of epithelial-to-mesenchymal transition in liver injuryDavid Scholten, Ralf Weiskirchen
Nature Clinical Practice. Gastroenterology & Hepatology|July 17, 2008
What is the potential role of antifibrotic agents for the treatment of liver disease?Bernd Schnabl, David Scholten, David A Brenner
World Journal of Biological Chemistry|June 13, 2014
Endoglin in liver fibrogenesis: Bridging basic science and clinical practiceSteffen K Meurer, Muhammad Alsamman, David Scholten, et al.
Hepatobiliary Surgery and Nutrition|February 26, 2015
Contribution of bone marrow-derived fibrocytes to liver fibrosisJun Xu, Min Cong, Tae Jun Park, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 31, 2021
Multiplexed Tissue TomographyEvan H Phillips, David Scholten, Amy C Flor, et al.
Cancers|February 13, 2025
Timing Anti-PD-L1 Checkpoint Blockade Immunotherapy to Enhance Tumor IrradiationSteve Seung-Young Lee, Joanna Pagacz, Sera Averbek, et al.
Gastroenterology|June 16, 2010
Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in miceDavid Scholten, Christoph H Osterreicher, Anjali Scholten, et al.
International Review of Cell and Molecular Biology|April 26, 2025
Circulation tumor cell isolation and enrichment technologiesYoubin Zhang, David Scholten, Wenan Qiang, et al.
Plos One|June 27, 2013
The chemokine CCL3 promotes experimental liver fibrosis in miceDaniel Heinrichs, Marie-Luise Berres, Andreas Nellen, et al.
Journal of Internal Medicine|November 22, 2022
Intravenous immunoglobulins in the treatment of post-COVID: A case-control studyMaximilian Hogeweg, Adrian Doevelaar, Sonja Rieckmann, et al.
Pageof 4